Skip to main content

Amneal Pharmaceuticals, Inc.

AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723128

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Amneal Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
238
+39 vs. Q4 2024
Shares held
135.8M
+12.4M (+10.1%) vs. Q4 2024
Total value
$1.14B
+$160.9M (+16.5%) vs. Q4 2024
New holders
53
91 more added
Sold out
14
53 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 238 institutions
Q1 2021: 161 institutionsQ2 2021: 160 institutionsQ3 2021: 155 institutionsQ4 2021: 154 institutionsQ1 2022: 168 institutionsQ2 2022: 153 institutionsQ3 2022: 155 institutionsQ4 2022: 157 institutionsQ1 2023: 145 institutionsQ2 2023: 128 institutionsQ3 2023: 144 institutionsQ4 2023: 153 institutionsQ1 2024: 176 institutionsQ2 2024: 182 institutionsQ3 2024: 183 institutionsQ4 2024: 200 institutionsQ1 2025: 238 institutionsQ2 2025: 241 institutionsQ3 2025: 248 institutionsQ4 2025: 278 institutionsQ1 2026: 317 institutionsQ2 2026: 311 institutions
Value heldQ1 2025: $1.14B
Q1 2021: $683.6MQ2 2021: $511.6MQ3 2021: $535.3MQ4 2021: $481.1MQ1 2022: $417.2MQ2 2022: $316.0MQ3 2022: $201.0MQ4 2022: $202.7MQ1 2023: $134.7MQ2 2023: $302.0MQ3 2023: $430.0MQ4 2023: $663.1MQ1 2024: $655.2MQ2 2024: $880.5MQ3 2024: $1.19BQ4 2024: $998.7MQ1 2025: $1.14BQ2 2025: $1.16BQ3 2025: $1.51BQ4 2025: $1.95BQ1 2026: $2.00BQ2 2026: $2.82B
Institutions holding AMRX and their total value by quarter
QuarterHoldersValue
Q2 2026311$2.82B
Q1 2026317$2.00B
Q4 2025278$1.95B
Q3 2025248$1.51B
Q2 2025241$1.16B
Q1 2025238$1.14B
Q4 2024200$998.7M
Q3 2024183$1.19B
Q2 2024182$880.5M
Q1 2024176$655.2M
Q4 2023153$663.1M
Q3 2023144$430.0M
Q2 2023128$302.0M
Q1 2023145$134.7M
Q4 2022157$202.7M
Q3 2022155$201.0M
Q2 2022153$316.0M
Q1 2022168$417.2M
Q4 2021154$481.1M
Q3 2021155$535.3M
Q2 2021160$511.6M
Q1 2021161$683.6M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Amneal Pharmaceuticals, Inc.; share changes are against Q4 2024.

Institutions holding AMRX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Numerai GP LLC596,131$5.00M0.94%+596,131New
Raymond James Financial Inc596,502$5.00M0.00%+224,506+60.4%Added
Bank of New York Mellon Corp598,389$5.01M0.00%−25,449−4.1%Reduced
Renaissance Technologies LLC624,700$5.23M0.01%−61,800−9.0%Reduced
Trexquant Investment LP630,351$5.28M0.06%+167,631+36.2%Added
Cubist Systematic Strategies, LLC684,116$5.73M0.08%+684,116New
Balyasny Asset Management LLC719,080$6.03M0.02%+546,767+317.3%Added
AQR Capital Management LLC745,475$6.25M0.01%+408,677+121.3%Added
Assenagon Asset Management S.A.819,736$6.87M0.01%+59,267+7.8%Added
Goldman Sachs Group Inc937,189$7.85M0.00%−36,556−3.8%Reduced
JPMorgan Chase & Co1,091,690$9.15M0.00%−123,282−10.1%Reduced
Tucker Asset Management LLC1,111,064$9.31M3.02%00.0%Unchanged
Phocas Financial Corp.1,259,378$10.6M1.62%−71,035−5.3%Reduced
Prudential Financial Inc1,376,656$11.5M0.02%+192,875+16.3%Added
Hennessy Advisors Inc1,499,400$12.6M0.42%−171,200−10.2%Reduced
Woodline Partners LP1,504,095$12.6M0.08%+937,035+165.2%Added
Morgan Stanley1,621,001$13.6M0.00%+133,240+9.0%Added
Ameriprise Financial Inc1,663,336$13.9M0.00%+124,089+8.1%Added
Northern Trust Corp1,708,627$14.3M0.00%−68,656−3.9%Reduced
Qube Research & Technologies Ltd1,765,965$14.8M0.02%+467,959+36.1%Added
Charles Schwab Investment Management Inc1,767,594$14.8M0.00%+227,660+14.8%Added
Arrowstreet Capital, Limited Partnership1,793,453$15.0M0.01%+252,395+16.4%Added
UBS Group AG1,812,375$15.2M0.00%+146,850+8.8%Added
Millennium Management LLC2,087,398$17.5M0.02%+762,842+57.6%Added
Invesco Ltd.2,272,713$19.0M0.00%+365,467+19.2%Added
Nuveen, LLC2,336,628$19.6M0.01%+2,336,628New
Acadian Asset Management LLC2,598,294$21.8M0.06%+880,471+51.3%Added
BlackBarn Capital Partners LP2,881,654$24.1M8.25%+31,654+1.1%Added
State Street Corp3,690,354$30.9M0.00%−7,792−0.2%Reduced
Neuberger Berman Group LLC3,735,083$31.4M0.03%−27,664−0.7%Reduced
Nantahala Capital Management, LLC3,808,561$31.9M2.64%+143,032+3.9%Added
Geode Capital Management, LLC3,825,411$32.1M0.00%+12,204+0.3%Added
Dimensional Fund Advisors LP5,103,156$42.8M0.01%+111,454+2.2%Added
Citadel Advisors LLC7,492,029$62.8M0.06%−1,488,939−16.6%Reduced
Rubric Capital Management LP10,735,977$90.0M1.61%+14,199+0.1%Added
TPG GP A, LLC12,328,767$103.3M2.08%00.0%Unchanged
BlackRock, Inc.12,587,778$105.5M0.00%−2320.0%Reduced
Vanguard Group Inc15,762,727$132.1M0.00%+920,758+6.2%Added
ExodusPoint Capital Management, LP0$00.00%−108,267−100.0%Sold out
Bellevue Group AG0$00.00%−100,414−100.0%Sold out
Signature Wealth Management Partners, LLC0$00.00%−66,666−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−58,111−100.0%Sold out
Tranquilli Financial Advisor LLC0$00.00%−51,414−100.0%Sold out
Inceptionr LLC0$00.00%−41,921−100.0%Sold out
Virtus Investment Advisers, Inc.0$00.00%−34,510−100.0%Sold out
Entropy Technologies, LP0$00.00%−32,757−100.0%Sold out
Vestcor Inc0$00.00%−31,393−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−20,435−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−13,571−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−12,274−100.0%Sold out
Straightline Group LLC0$00.00%−11,600−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−1,316−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed